Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

ARDX

Ardelyx (ARDX)

Ardelyx Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ARDX
일자시간출처헤드라인심볼기업
2024/05/3105:02GlobeNewswire Inc.Ardelyx, Inc. Reports Employment Inducement GrantsNASDAQ:ARDXArdelyx Inc
2024/05/2405:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARDXArdelyx Inc
2024/05/2405:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
2024/05/2405:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
2024/05/2405:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
2024/05/2405:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
2024/05/2405:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
2024/05/2405:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
2024/05/2221:02GlobeNewswire Inc.Ardelyx to Participate at the 2024 Jefferies Global Healthcare ConferenceNASDAQ:ARDXArdelyx Inc
2024/05/2121:02GlobeNewswire Inc.Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in AdultsNASDAQ:ARDXArdelyx Inc
2024/05/1621:01GlobeNewswire Inc.Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)NASDAQ:ARDXArdelyx Inc
2024/05/1505:02GlobeNewswire Inc.Ardelyx, Inc. Reports Employment Inducement GrantsNASDAQ:ARDXArdelyx Inc
2024/05/1005:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
2024/05/0805:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
2024/05/0721:01GlobeNewswire Inc.Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week ConferenceNASDAQ:ARDXArdelyx Inc
2024/05/0305:02GlobeNewswire Inc.Ardelyx Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ARDXArdelyx Inc
2024/05/0121:00GlobeNewswire Inc.Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical MeetingsNASDAQ:ARDXArdelyx Inc
2024/04/1821:00GlobeNewswire Inc.Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024NASDAQ:ARDXArdelyx Inc
2024/03/2905:05GlobeNewswire Inc.Ardelyx, Inc. Reports Employment Inducement GrantsNASDAQ:ARDXArdelyx Inc
2024/03/2521:00GlobeNewswire Inc.Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and StrategyNASDAQ:ARDXArdelyx Inc
2024/03/1305:35GlobeNewswire Inc.Ardelyx, Inc. Reports Employment Inducement GrantsNASDAQ:ARDXArdelyx Inc
2024/03/0606:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARDXArdelyx Inc
2024/02/2908:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
2024/02/2722:00GlobeNewswire Inc.Ardelyx to Participate at the Cowen 44th Annual Health Care ConferenceNASDAQ:ARDXArdelyx Inc
2024/02/2308:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
2024/02/2307:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
2024/02/2306:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
2024/02/2306:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
2024/02/2306:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
2024/02/2306:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
 검색 관련기사 보기:NASDAQ:ARDX